The global cell isolation market size was USD 5.83 billion in 2022 and is expected to reach USD 18.96 billion in 2032 and register at a CAGR of 14% during the forecast period. Cell-based therapies use living cells to treat a range of illnesses and conditions, including cancer, cardiovascular disease, and neurological disorders. The cell isolation products market revenue growth is being driven by increasing prevalence of these disorders and rising demand for cell-based therapeutics. Need for cell separation products is also being driven by development of tailored medications and rising emphasis on Regenerative Medicine.
Another key factor driving revenue growth of the cell isolation market is government financing for scientific endeavors. Governments across the globe are making significant investments in research projects involving Stem Cells, cancer research, and other areas that call for the utilization of cell isolation products. This investment makes it possible to create cutting-edge cell separation solutions, which is fueling the market's expansion.
Revenue growth of the market is driven by technological developments in cell isolation methods. The effectiveness and precision of cell separation methods are being enhanced by the development of new and better cell isolation techniques as Magnetic-activated Cell Sorting (MACS), Fluorescence-Activated Cell Sorting (FACS), and microfluidic cell sorting. Moreover, revenue growth of the market is driven by rising implementation of automation in cell isolation techniques.
Revenue growth of the market for cell isolation is also being driven by rising popularity of cell-based tests and cell culture research. Drug effectiveness and toxicity are evaluated using cell-based assays, and the behavior of cells in cultured conditions is investigated. Need for cell isolation solutions is being driven by the expanding market for these applications.
However, expensive cost of cell separation products, a dearth of qualified personnel, and moral concerns about the use of embryonic stem cells, are major factors, which could restrain revenue growth of the market.
Product Type Outlook:
Based on product type, the cell isolation market has been divided into reagents & kits, instruments, and consumables. Reagents and kits accounted for the biggest revenue proportion of all of these in 2021. The market is expanding as a result of the growing need for efficient and effective cell isolation products. Applications for reagents and kits include, among others, drug development, stem cell research, and cancer research. The demand for reagents and kits in the cell isolation market is anticipated to be driven by the rising prevalence of chronic diseases and rising investments in life sciences research and development.
The largest revenue CAGR is anticipated for instruments over the projection period. The use of cutting-edge technologies in cell isolation equipment, including flow cytometry, magnetic-activated cell sorting (MACS), and microfluidics, among others, is said to be the cause of the growth. These tools give high purity and yield of separated cells and assist in isolating cells based on their physical and chemical characteristics. The need for instruments in the cell isolation market is being driven by the rising incidence of infectious and cancerous disorders as well as rising spending in R&D activities.
During the projection year, consumption is anticipated to expand significantly as well. Consumables for cell isolation are in higher demand because to an increase in research activities, expanding biotechnology and pharmaceutical industry investments, and rising public awareness of customised treatment. Consumables are widely utilised in a variety of applications, including cell treatment, gene therapy, and immunotherapy, among others. Examples of these uses include Filters, membranes, and columns.
Depending on the application, the market for cell isolation has been divided into biomolecule isolation, cancer research, stem cell research, tissue regeneration & regenerative medicine, and others. In 2021, biomolecule isolation had the highest revenue share of all of them. The expansion of the biomolecule isolation market is being driven by the rising need for pure biomolecules for numerous applications, including drug discovery, proteomics, and genomics, among others. Biomolecule isolation is frequently accomplished via cell isolation techniques including ultracentrifugation, electrophoresis, and chromatography, among others.
Throughout the forecast period, cancer research is anticipated to have the greatest revenue CAGR. The rise in investments in cancer research and development activities as well as the increased incidence of cancer are credited with the growth. For the isolation and analysis of cancer cells, cell isolation techniques like flow cytometry, MACS, and fluorescence-activated cell sorting (FACS) are frequently employed in cancer research. The desire for focused therapies and personalised medicine is also boosting the market for cancer research.
Throughout the anticipated decade, stem cell research is also anticipated to experience significant increase. The demand for stem cell isolation techniques is being driven by rising investments in stem cell research and development activities as well as rising public awareness of regenerative medicine. For the isolation and study of stem cells, a variety of cell isolation techniques, including MACS and FACS, are frequently used. The rise in customised medicine demand and the prevalence of chronic diseases like diabetes and cardiovascular disease are both factors in the expansion of the stem cell research industry.
Another significant application area in the cell isolation industry is tissue regeneration and regenerative medicine. The growth of the tissue regeneration & regenerative medicine segment is being fueled by rising investments in R&D activities as well as rising demand for Tissue Engineering and regenerative medicine. Techniques for isolating cells for tissue engineering and regenerative medicine applications, such collagenase digestion, are frequently used.
Regional Insights: The North American market is anticipated to lead the way in the global cell isolation industry's anticipated rapid rise in the upcoming years. The prevalence of chronic diseases is increasing, the desire for personalised medicine is expanding, and the government is increasing funding for cell-based research and development. Due to its advanced healthcare system, sizable research and development sector, and rising investment in biotechnology research, North America is predicted to experience the fastest revenue increase.
The cell isolation market is anticipated to expand quickly in Asia Pacific as a result of factors like rising healthcare costs, a sizable patient base, and rising interest in cutting-edge cell separation methods. There are several developing nations in the area, such as China and India, where the prevalence of chronic diseases is rising. In addition, it is anticipated that numerous major participants in the cell isolation business will move to the area due to the region's accessibility to qualified personnel and affordable production costs.
The European market is anticipated to expand moderately, propelled by factors including rising government spending for life sciences research and development and the prevalence of chronic disorders. Thermo Fisher Scientific, STEMCELL Technologies, and Merck KGaA are just a few of the key firms based in the area that are active in the cell isolation market.
launches of new products:
The ddPCR Multiplexing Supermix for Probes, a reagent kit for digital droplet PCR (ddPCR) analysis, was introduced by Bio-Rad Laboratories, Inc. in 2020. The product's objective is to identify and quantify several targets in a single sample with accurate and dependable findings.
Segments Covered in the Report:
By Product Type
By Cell Type